JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Pfizer
PFE
|
+$919M |
| 3 |
Microsoft
MSFT
|
+$718M |
| 4 |
Wells Fargo
WFC
|
+$679M |
| 5 |
PepsiCo
PEP
|
+$641M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$1.62B |
| 2 |
Johnson & Johnson
JNJ
|
+$1.19B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$754M |
| 4 |
Booking.com
BKNG
|
+$726M |
| 5 |
SLB Ltd
SLB
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.42% |
| 2 | Financials | 13.44% |
| 3 | Healthcare | 11.49% |
| 4 | Technology | 10.73% |
| 5 | Consumer Discretionary | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GNCMA
2651
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $2.29M | ﹤0.01% |
+145,163
| New | +$2.13M |
2015 Q1
0 quarters
|
|
|
TRNX
2652
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.27M | ﹤0.01% |
86,516
+28,812
| +50% | +$730K |
2014 Q4
1 quarter
|
|
2653
Lakeland Financial Corp
LKFN
$1.44B
| $2.26M | ﹤0.01% |
83,666
+4,913
| +6% | +$131K |
2013 Q2
7 quarters
|
|
|
OREX
2654
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.25M | ﹤0.01% |
28,768
-56,675
| -66% | -$3.52M |
2013 Q2
7 quarters
|
|
2655
PUT
HF Sinclair
DINO
$20B
| $2.25M | ﹤0.01% |
+55,900
| New | +$2.14M |
2015 Q1
0 quarters
|
|
2656
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.35B
| $2.24M | ﹤0.01% |
44,237
+25,037
| +130% | +$1.23M |
2013 Q2
7 quarters
|
|
|
ANAC
2657
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $2.23M | ﹤0.01% |
38,599
+30,169
| +358% | +$1.28M |
2014 Q4
1 quarter
|
|
|
WAGE
2658
DELISTED
WageWorks, Inc.
WAGE
| $2.23M | ﹤0.01% |
41,829
-75,415
| -64% | -$4.3M |
2013 Q2
7 quarters
|
|
|
CAB
2659
DELISTED
Cabela's Inc
CAB
| $2.23M | ﹤0.01% |
39,857
+21,205
| +114% | +$1.17M |
2013 Q2
7 quarters
|
|
|
OPPE
2660
WisdomTree European Opportunities Fund
OPPE
$284M
| $2.23M | ﹤0.01% |
+85,732
| New | +$2.21M |
2015 Q1
0 quarters
|
|
2661
PUT
The Mosaic Company
MOS
$6.85B
| $2.22M | ﹤0.01% |
48,100
-22,800
| -32% | -$1.11M |
2014 Q2
3 quarters
|
|
|
CLR
2662
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.21M | ﹤0.01% |
50,548
-462,243
| -90% | -$19.7M |
2013 Q2
7 quarters
|
|
|
ENDP
2663
PUT
DELISTED
Endo International plc
ENDP
| $2.2M | ﹤0.01% |
24,532
+12,032
| +96% | +$1.01M |
2014 Q4
1 quarter
|
|
|
MRH
2664
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $2.19M | ﹤0.01% |
57,044
-6,555
| -10% | -$237K |
2013 Q2
7 quarters
|
|
|
PBCT
2665
DELISTED
People's United Financial Inc
PBCT
| $2.19M | ﹤0.01% |
144,117
-195,413
| -58% | -$2.9M |
2013 Q2
7 quarters
|
|
2666
CGI
GIB
$14.7B
| $2.16M | ﹤0.01% |
+50,927
| New | +$2.08M |
2015 Q1
0 quarters
|
|
2667
ProShares VIX Short-Term Futures ETF
VIXY
$220M
| $2.16M | ﹤0.01% |
79
+62
| +365% | +$2M |
2013 Q2
7 quarters
|
|
2668
Eledon Pharmaceuticals
ELDN
$198M
| $2.16M | ﹤0.01% |
1,178
-30
| -2% | -$66.2K |
2014 Q3
2 quarters
|
|
2669
Griffon
GFF
$4.22B
| $2.15M | ﹤0.01% |
123,400
-10,176
| -8% | -$157K |
2013 Q2
7 quarters
|
|
2670
Element Solutions
ESI
$8.85B
| $2.15M | ﹤0.01% |
83,757
-4,270
| -5% | -$103K |
2014 Q3
2 quarters
|
|
|
OMED
2671
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $2.15M | ﹤0.01% |
+83,247
| New | +$2.11M |
2015 Q1
0 quarters
|
|
|
AYR
2672
DELISTED
Aircastle Ltd
AYR
| $2.15M | ﹤0.01% |
+95,556
| New | +$2.08M |
2015 Q1
0 quarters
|
|
2673
Liquidity Services
LQDT
$1.37B
| $2.14M | ﹤0.01% |
217,094
-15,792
| -7% | -$142K |
2013 Q2
7 quarters
|
|
2674
Tiptree Inc
TIPT
$644M
| $2.14M | ﹤0.01% |
322,666
-220,000
| -41% | -$1.57M |
2014 Q4
1 quarter
|
|
|
OUTR
2675
PUT
DELISTED
OUTERWALL INC
OUTR
| $2.13M | ﹤0.01% |
+32,200
| New | +$2.15M |
2015 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2015 Portfolio in Review
As of Q1 2015, JP Morgan Chase held 4,553 positions worth $439B, up 0.39% from $437B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2015 filing shows 344 new, 1,711 increased, 1,692 reduced and 516 closed positions. Its largest new stake was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M. The largest sale was iShares MSCI EAFE ETF, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q1 2015 buy was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2015 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.62B.
- JP Morgan Chase fully exited CAREFUSION CORPORATION in Q1 2015, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 16% of its $439B portfolio in Q1 2015.
- JP Morgan Chase opened 344 new positions and closed 516 in Q1 2015.
- JP Morgan Chase's portfolio value rose 0.39% quarter-over-quarter to $439B.
Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.